International Journal of Nanomedicine · 2021 · 11 citations · 26 references
MedicineBiomedical EngineeringMedicinal ChemistryBiomedical ImagingDiagnostic ImagingNanomaterialsMagnetic Resonance ImagingMultimodal ImagingNanomedicineNanoparticle DesignTargeted Imaging AgentsTumor ImagingContrast Agent SynthesisMultifunctional NanoparticlesNanoparticle Contrast AgentsNanoparticle Imaging AgentsNanoparticle Imaging ProbesNanoparticle-based Contrast AgentsNanoparticlesT2-weighted Imaging
Background: Development of new long-circulating contrast agents for computed tomography (CT) and magnetic resonance imaging (MRI) of different biological systems still remains a great challenge. Here, we report the synthesis of folic acid (FA)-targeted CuFeSe 2 nano-contrast agent for CT and MRI imaging in vitro and in vivo. Methods and Results: In our study, CuFeSe 2 was fabricated through a facile and green aqueous reaction and then further aminated through silanization. The amine-functionalized CuFeSe 2 -NH 2 nanoparticles enable the covalent conjugation of folate-conjugated polyethylene glycol (FA-PEG-COOH) as a targeting ligand onto their surface, which could improve the dispersion and endue the targetability of nanoparticles, respectively. The formed multifunctional CuFeSe 2 -PEG-FA nanoparticles were characterized via different techniques, which exhibited outstanding dispersion, good biocompatibility and excellent FA-targeted capability. Meanwhile, the nanoparticles were quite safe in the given concentration range as confirmed by in vitro and in vivo toxicity assay. Importantly, CuFeSe 2 -PEG-FA nanoparticles were successfully applied in CT/MRI dual-modality imaging in vitro and in vivo, which showed a better imaging performance and targeted capability. Conclusion: Therefore, the constructed CuFeSe 2 -PEG-FA nanoparticles have a great potential as an efficient contrast agent for dual-modality imaging of different biological systems. Keywords: CuFeSe 2 nanoparticles, magnetic resonance imaging, computed tomography imaging, dual-modality imaging, folic acid
26
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Steven Weitman, Richard H. Lark, Leslie R. Coney et al. · PubMed · 1992 · 1K citations
Folate-binding protein is a marker for ovarian cancer.
Ian Campbell, T. Alwyn Jones, William D. Foulkes et al. · PubMed · 1991 · 459 citations
Myoung Hwan Oh, Nohyun Lee, Hyoungsu Kim et al. · Journal of the American Chemical Society · 2011 · 362 citations